Posts Posts by: "Tim Fell"

LONDON, 11 February 2015 – British bioengineering firm Synthace has closed a £2.2 million funding round with new investors SOSventures, Bioeconomy Capital and Rainbow Seed Fund joining Sofinnova Partners and other existing investors. Synthace develops and applies bioengineering tools and working practices, working with industry leaders to accelerate the introduction of bio-based products into…(Read More)

Antha is a language developed at Synthace to enable the rapid development, execution, and analysis of complex biological experiments.  Synthace is now releasing this language to the global community so that everyone can benefit from robust, reproducible and shareable biological experimentation. Antha elements are not locked into equipment from any single manufacturer, and can be…(Read More)